-

EOSE Investor Alert: Eos Energy Enterprises, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Automated Production Claims: Levi & Korsinsky

Time-Sensitive: Allegations Focus on Automated Bipolar Production Quality Representations

"Investors deserve transparency about material risks that could affect their investments, particularly when a company's public statements paint a picture of operational progress that allegedly diverges from manufacturing reality," stated Joseph E. Levi, Esq., managing partner of Levi & Korsinsky, LLP.

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP alerts investors in Eos Energy Enterprises, Inc. (NASDAQ: EOSE) of a pending securities class action. Class Period: November 5, 2025 through February 26, 2026. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

EOSE shares lost $4.39 per share, a 39.4% single-day decline, closing at $6.74 on February 26, 2026, after the Company disclosed that its automated bipolar production failed to hit quality targets, driving rework and lost revenue. The deadline to apply for lead plaintiff appointment is May 5, 2026.

The Alleged Automated Bipolar Quality Deficiency

The lawsuit asserts that throughout the Class Period, management promoted a narrative of smooth automation progress at its Turtle Creek manufacturing facility. Public statements highlighted that 88% of bipolar lines were in commercial production and that subassembly automation was advancing as planned. What shareholders were not told, the action claims, was that automated bipolar production was failing to meet quality targets, generating significant rework that consumed production capacity and destroyed revenue.

Zinc Battery Manufacturing Quality Challenges in Automated Environments

The securities action focuses on how quality failures in an automated production environment compound differently than in manual or semi-automated settings:

  • Automated bipolar production lines that cannot hit quality targets generate defective output at scale, multiplying rework costs with every hour of operation
  • Rework from quality failures allegedly consumed production time that had been counted toward revenue guidance of $150 million to $160 million
  • As alleged, tightened material specifications and improved tooling were not implemented until after quality problems had already eroded revenue
  • Laser detection systems for process variation control were added only after the damage, suggesting the original quality monitoring was allegedly inadequate
  • The gap between the Company's claimed automation progress and actual quality performance allegedly widened throughout Q4 2025
  • Actual full year revenue of $114.2 million fell $35.8 million to $45.8 million short of guidance, with quality-driven rework cited as a contributing factor

Why Automated Production Quality Allegedly Matters to Investors

The complaint contends that Eos Energy's investment thesis rested on its ability to scale zinc-based battery production through automation. When management represented that its first fully automated manufacturing line was installed and in commercial production, investors reasonably understood that quality benchmarks were being met. The action claims this representation was materially misleading because automated bipolar production was not hitting quality targets, a fact that directly undermined the revenue ramp that justified the Company's guidance and stock price.

Speak with an attorney about recovering damages or call (212) 363-7500.

WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NASDAQ:EOSE

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

MO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Altria Group (MO)

NEW YORK--(BUSINESS WIRE)--Altria Group (NYSE: MO) shareholders took losses in late July 2026 when the Company reported second-quarter earnings and revenue below consensus and cut its full-year outlook -- an outlook management had reaffirmed on April 30, 2026 at adjusted diluted EPS of $5.56 to $5.72. If you suffered a loss on your Altria Group investment, you are encouraged to click here to submit your Altria loss information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikor...

TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)

NEW YORK--(BUSINESS WIRE)--Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 billion, Teladoc Health (NYSE: TDOC) reduced that outlook to $2.36 billion to $2.45 billion, and shares fell nearly 30%. If you lost money holding Teladoc Health shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.On the February 25, 2026 fourth qua...

PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)

NEW YORK--(BUSINESS WIRE)--A 22% single-session drop hit Pharming Group (PHAR) shares today after the Company reported Q2 2026 revenue of $90.2 million -- a 3% year-over-year decline against analyst consensus of roughly $419 million for the full year. If you lost money on PHAR, click here to submit your losses for review. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.The miss came from the Company's legacy product. RUCONEST sales...
Back to Newsroom